TY - JOUR
T1 - Urinary physiologic and chemical metabolic effects on the urothelial cytotoxicity and potential DNA adducts of o-phenylphenol in male rats
AU - Smith, Raymond A.
AU - Christenson, W. Russ
AU - Bartels, Michael J.
AU - Arnold, Lora L.
AU - St. John, Margaret K.
AU - Cano, Martin
AU - Garland, Emily M.
AU - Lake, Stephen G.
AU - Wahle, Bradley S.
AU - McNett, Debra A.
AU - Cohen, Samuel M.
N1 - Funding Information:
We gratefully acknowledge the technical assistance of Traci Anderson, A. M. Landes, M. F. Mejia, B. A. Longmoor, D. M. Offutt, K. Brzak, and S. Shabrang, and the assistance of Denise Miller and Michelle Moore with the preparation of this manuscript. This work was supported by a contract from Bayer Corporation and the Dow Chemical Company. Some of the work reported in this manuscript has been presented at the 88th Annual Meeting of the American Association for Cancer Research, April 12–16, 1997, at San Diego, CA.
PY - 1998/6
Y1 - 1998/6
N2 - ortho-Phenylphenol (OPP), a fungicide and antibacterial agent with food residues, is carcinogenic to rat bladder. The present studies provide information on changes in urinary composition and urinary metabolites, urothelial cytotoxicity and regenerative hyperplasia, and DNA adducts in male F344 rats fed OPP. An initial experiment evaluated dietary doses of 0, 1,000, 4,000, and 12,500 ppm OPP fed for 13 weeks. There was no evidence of urinary calculi, microcrystalluria, or calcium phosphate-containing precipitate, but urothelial cytotoxicity and hyperplasia occurred at the highest dose only. In a second experiment, rats were fed dietary OPP levels of 0, 800, 4,000, 8,000, and 12,500 ppm. Urinary pH was >7 in all groups. Urinary volume was increased at the 2 highest doses with consequent decreases in osmolality, creatinine, and other solutes. Total urinary OPP metabolite excretions were increased, mostly excreted as conjugates of OPP and of phenylhydroquinone. Free OPP or free metabolites accounted for less than 2% excreted in the urine without a dose response. Urothelial toxicity and hyperplasia occurred only at doses of 8,000 and 12,500 ppm. OPP-DNA adducts were not detected in the urothelium at any dose. In summary, OPP produces cytotoxicity and proliferation of the urothelium at dietary doses ≤8,000 ppm without formation of urinary solids. The paucity of unconjugated metabolites and the lack of OPP-DNA adducts suggests that OPP is acting as a bladder carcinogen in male rats by inducing cytotoxicity and hyperplasia without it or its metabolites directly binding to DNA.
AB - ortho-Phenylphenol (OPP), a fungicide and antibacterial agent with food residues, is carcinogenic to rat bladder. The present studies provide information on changes in urinary composition and urinary metabolites, urothelial cytotoxicity and regenerative hyperplasia, and DNA adducts in male F344 rats fed OPP. An initial experiment evaluated dietary doses of 0, 1,000, 4,000, and 12,500 ppm OPP fed for 13 weeks. There was no evidence of urinary calculi, microcrystalluria, or calcium phosphate-containing precipitate, but urothelial cytotoxicity and hyperplasia occurred at the highest dose only. In a second experiment, rats were fed dietary OPP levels of 0, 800, 4,000, 8,000, and 12,500 ppm. Urinary pH was >7 in all groups. Urinary volume was increased at the 2 highest doses with consequent decreases in osmolality, creatinine, and other solutes. Total urinary OPP metabolite excretions were increased, mostly excreted as conjugates of OPP and of phenylhydroquinone. Free OPP or free metabolites accounted for less than 2% excreted in the urine without a dose response. Urothelial toxicity and hyperplasia occurred only at doses of 8,000 and 12,500 ppm. OPP-DNA adducts were not detected in the urothelium at any dose. In summary, OPP produces cytotoxicity and proliferation of the urothelium at dietary doses ≤8,000 ppm without formation of urinary solids. The paucity of unconjugated metabolites and the lack of OPP-DNA adducts suggests that OPP is acting as a bladder carcinogen in male rats by inducing cytotoxicity and hyperplasia without it or its metabolites directly binding to DNA.
UR - http://www.scopus.com/inward/record.url?scp=17144466764&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=17144466764&partnerID=8YFLogxK
U2 - 10.1006/taap.1998.8435
DO - 10.1006/taap.1998.8435
M3 - Article
C2 - 9653072
AN - SCOPUS:17144466764
SN - 0041-008X
VL - 150
SP - 402
EP - 413
JO - Toxicology and Applied Pharmacology
JF - Toxicology and Applied Pharmacology
IS - 2
ER -